Syncope, commonly known as fainting, is a prevalent clinical condition characterized by a temporary loss of consciousness and postural tone. It is a complex symptom with a broad spectrum of underlying causes, ranging from benign to life-threatening. This article aims to provide a comprehensive approach to the evaluation and management of syncope.
Syncope results from transient global cerebral hypoperfusion. The causes can be broadly classified into three categories: reflex (neurally-mediated), cardiac, and orthostatic hypotension. Reflex syncope is the most common, while cardiac syncope has the highest mortality risk.
A detailed history and physical examination are crucial in the assessment of syncope. Key points include the circumstances leading to the event, presence of prodromal symptoms, and post-event recovery. A thorough cardiovascular examination should be performed to rule out cardiac causes. Additional diagnostic tests may be warranted based on the initial evaluation.
The management of syncope is tailored to its underlying cause. Reflex syncope may be managed with lifestyle modifications and patient education. Cardiac syncope requires prompt identification and treatment of the underlying cardiac condition. Orthostatic hypotension may be managed with volume expansion, physical countermeasures, and pharmacotherapy.
The prognosis of syncope largely depends on its etiology. While reflex syncope generally has a good prognosis, cardiac syncope is associated with increased morbidity and mortality. Early identification and management of the underlying cause are crucial in improving the patient’s prognosis.
Understanding syncope requires a comprehensive approach, encompassing a detailed clinical evaluation, appropriate diagnostic testing, and targeted management strategies. By adopting such an approach, healthcare professionals can effectively manage syncope, improving patient outcomes and reducing healthcare costs.
1.
Tumor characteristics found to differ for melanomas in children, teens and young adults
2.
Unexplained CAR-T Death; Americans Spurn Sunscreen; Improving Diversity in Trials
3.
"A lot" of aspirin reduces the risk of ovarian cancer, regardless of genetic factors, according to the JAMA study.
4.
Approval in Endometrial Cancer Expanded; Masks at Cancer Centers; NPR Reporter Dies
5.
Is Lenalidomide Resistance in Myeloma Reversible with JAK Inhibition?
1.
Modern Oncology Unveiled with Treatment Innovations and Personalized Cancer Care
2.
Screening for Early Therapy-Related Cancer Susceptibility
3.
Unlocking the Potential of Bicalutamide 50 mg: A Revolutionary New Treatment for Prostate Cancer
4.
Skin-Sparing Mastectomy: Balancing Cancer Control with Cosmetic Results
5.
Reducing Modifiable Childhood Cancer Exposure Risks
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
2.
Targeting Oncologic Drivers with Dacomitinib: Further Discussion on Lung Cancer Treatment
3.
Should We Use DARA Up Front As First-Line Therapy in MM?
4.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- A New Perspective
5.
Importance of Cancer Screening and Early Detection
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation